isoproterenol has been researched along with Cachexia in 5 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "During a study of the mechanism of cancer cachexia, a debilitating condition in which catabolism of host muscle and adipose tissue occurs, it has been observed that the process can be effectively reversed in vivo by the polyunsaturated fatty acid, eicosapentaenoic acid (EPA), but not by other PUFA of either the n-3 or n-6 series." | 8.78 | Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein. ( Tisdale, MJ, 1993) |
| "During a study of the mechanism of cancer cachexia, a debilitating condition in which catabolism of host muscle and adipose tissue occurs, it has been observed that the process can be effectively reversed in vivo by the polyunsaturated fatty acid, eicosapentaenoic acid (EPA), but not by other PUFA of either the n-3 or n-6 series." | 4.78 | Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein. ( Tisdale, MJ, 1993) |
| "The response to glucagon and adrenaline in cancer cachexia is poorly known." | 3.88 | Decreased hepatic response to glucagon, adrenergic agonists, and cAMP in glycogenolysis, gluconeogenesis, and glycolysis in tumor-bearing rats. ( Bertolini, GL; Biazi, GR; de Fatima Silva, F; de Morais, H; de Souza, HM; Frasson, IG; Miksza, DR, 2018) |
| " In this study, both LMF and Zn-alpha2-glycoprotein have been shown to stimulate glycerol release from isolated murine epididymal adipocytes with a comparable dose-response profile." | 1.30 | Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. ( Barber, MD; Hirai, K; Hussey, HJ; Price, SA; Tisdale, MJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biazi, GR | 1 |
| Frasson, IG | 1 |
| Miksza, DR | 1 |
| de Morais, H | 1 |
| de Fatima Silva, F | 1 |
| Bertolini, GL | 1 |
| de Souza, HM | 1 |
| Tisdale, MJ | 3 |
| Hirai, K | 1 |
| Hussey, HJ | 1 |
| Barber, MD | 1 |
| Price, SA | 2 |
| Seelaender, MC | 1 |
| Kazantzis, M | 1 |
| Costa Rosa, LF | 1 |
| Islam-Ali, B | 1 |
| Khan, S | 1 |
1 review available for isoproterenol and Cachexia
| Article | Year |
|---|---|
Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein.
Topics: Adenocarcinoma; Adenylyl Cyclases; Adipose Tissue; Animals; Cachexia; Colonic Neoplasms; Cyclic AMP; | 1993 |
4 other studies available for isoproterenol and Cachexia
| Article | Year |
|---|---|
Decreased hepatic response to glucagon, adrenergic agonists, and cAMP in glycogenolysis, gluconeogenesis, and glycolysis in tumor-bearing rats.
Topics: Adenosine Triphosphate; Adrenergic Agonists; Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-A | 2018 |
Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Topics: Adenylyl Cyclases; Adipocytes; Adrenergic beta-Agonists; Animals; Body Composition; Cachexia; Cells, | 1998 |
The effect of adrenaline and Walker-256 tumour-induced cachexia upon Kupffer cell metabolism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Buclades | 1999 |
Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF).
Topics: Adenylyl Cyclases; Adipocytes; Animals; Appetite Depressants; Cachexia; Cell Membrane; Colforsin; Ei | 2001 |